US Stock MarketDetailed Quotes
SNY Sanofi
- 48.720
- +0.440+0.91%
Close Nov 27 16:00 ET
- 48.720
- 0.0000.00%
Post 20:01 ET
122.15BMarket Cap25.68P/E (TTM)
48.980High48.410Low1.52MVolume48.450Open48.280Pre Close74.21MTurnover0.07%Turnover Ratio21.44P/E (Static)2.51BShares58.97052wk High1.59P/B107.46BFloat Cap43.38152wk Low2.10Dividend TTM2.21BShs Float58.970Historical High4.30%Div YieldTTM1.18%Amplitude8.844Historical Low48.707Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees87994
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Jean-Baptiste Chasseloup De Chatillon
- Executive Vice President and Chief Financial Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Frederic Oudea
- Chairman of the Board
- --
- Wolfgang Laux
- Director
- --
- Christophe Babule
- Director
- --
- Yann Tran
- Director
- --
- Barbara Lavernos
- Director
- --
- Carole Ferrand
- Independent Director
- --
- Fabienne Lecorvaisier
- Independent Director
- --
- Gilles Schnepp
- Independent Director
- --
- Patrick Kron
- Independent Director
- --
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- --
- Rachel Duan
- Independent Director
- --
- Lise Kingo
- Independent Director
- --
- Diane Souza
- Independent Director
- --
- Emile Voest
- Independent Director
- --
- Thomas Sudhof
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
